Preoperative High Level of Circulating Tumor Cells is an Independent Risk Factor for Central Lymph Node Metastasis in Papillary Thyroid Carcinoma with Maximum Lesion Diameter ≤1.0 cm
Ming Yu,Jiaqin Deng,Yihua Gu,Yeqian Lai
DOI: https://doi.org/10.2147/ijgm.s487992
IF: 2.145
2024-10-26
International Journal of General Medicine
Abstract:Ming Yu, Jiaqin Deng, Yihua Gu, Yeqian Lai Department of Thyroid Surgery, Meizhou People's Hospital, Meizhou Academy of Medical Sciences, Meizhou, People's Republic of China Correspondence: Ming Yu, Department of Thyroid Surgery, Meizhou People's Hospital, Meizhou, People's Republic of China, Email Objective: Circulating tumor cell (CTC) has been used to assist in the diagnosis and progression assessment of solid tumors, but the relationship between preoperative CTCs levels and central lymph node metastasis (CLNM) of papillary thyroid carcinoma (PTC) needs to be clarified. Methods: Data on clinical features (age, gender, Hashimoto's thyroiditis, multifocal, maximum lesion diameter, invaded capsule, clinical stage, and status of lymph node metastasis) of PTC patients treated at our hospital between June 2021 and April 2023 were retrospectively collected. The relationship between the CTCs level and these clinical features was analyzed, especially the relationship between the CTCs level and CLNM. Results: A total of 705 PTC patients were included, and there were 333 (47.2%) patients with CLNM. Patients with a high CTCs level had higher proportions of multifocality, maximum lesion diameter > 1cm, and CLNM than those in patients with a low CTCs level. Tumor size was connected to CTCs level, patients with a high CTCs level had a higher proportion of CLNM than those with a low CTCs level in PTC with maximum lesion diameter ≤ 1cm (45.3% vs 29.7%) ( p =0.001). Logistic regression analysis showed that age < 55 years old (odds ratio (OR): 2.612, 95% confidence interval (CI): 1.565– 4.361, p < 0.001), invaded capsule (OR: 1.662, 95% CI: 1.098– 2.517, p =0.016), and high CTCs level (≥ 8.7 FU/3mL, OR: 2.141, 95% CI: 1.431– 3.203, p < 0.001) were associated with CLNM in PTC with maximum lesion diameter ≤ 1cm. Conclusion: In PTC patients with maximum lesion diameter ≤ 1cm, patients with high preoperative CTCs level (≥ 8.7FU/3mL), age 1cm. Keywords: papillary thyroid carcinoma, circulating tumor cell, central lymph node metastasis, lymph node metastasis Thyroid carcinoma is one of the most common malignancies of the endocrine system with increasing incidence. 1,2 The global cancer statistics in 2020 showed that there were 586,000 new cases, ranking ninth in the global incidence of cancer, and the incidence of women is about 3 times that of men. 3 According to the statistics of the National Cancer Center of China in 2022, thyroid cancer ranking 7th in the incidence of cancer in China. 4 Papillary thyroid cancer (PTC) is one of the least aggressive types of thyroid cancer and rarely develops distant metastases. However, compared with other types of thyroid cancer, PTC has a higher proportion of lymph node metastasis. 5–8 The process of lymph node metastasis (LNM) in PTC is generally from the central lymph node to the lateral cervical lymph node, and a few patients have skip lymph node metastasis. 9 The central cervical region is the most common lymph node metastasis site for PTC, and the incidence of central lymph node metastasis (CLNM) is about 30%-90%, but the preoperative detection rate is low. 10,11 LNM is an important factor affecting the prognosis of PTC, it is very important to evaluate LNM, especially CLNM, in PTC patients. 12 There is no doubt that therapeutic lymph node dissection should be performed in patients with high suspicion and certainty of CLNM, but more researches are needed to provide guidance to clinicians on whether patients with negative lymph node metastases should undergo prophylactic central lymph node dissection. 13–15 Ultrasound and computed tomography (CT) are the methods for screening thyroid nodules and evaluating cervical lymph nodes, but the sensitivity of these methods is disputed. 10,16 On the other hand, ultrasonography (US)-guided fine needle aspiration cytology (UG-FNAC) provides fewer cells for pathological examination and can only observe cell changes, which cannot fully reflect the overall situation of tissue structure. 17,18 Therefore, it is of great value to analyze the risk factors of CLNM according to the clinical characteristics of PTC patients, to provide a simple tool for clinicians to predict the CLNM of PTC. Several factors have been identified as risk factors for CLNM in PTC patients, such as gender, age, body mass index (BMI), tumor size, multifocality, and B-Raf proto-oncogene (BRAF) V600E mutation. 19–22 Circulating tumor cell (CTC) is a type of tumor cell released by tumor tissu -Abstract Truncated-
medicine, general & internal